Back

Anterior middle cingulate cortex gamma-aminobutyric acid level is elevated in children with both familial and prenatal alcohol exposure-associated attention deficit hyperactivity disorder

Alger, J. R.; Gupta, I.; Farkouh, L.; Korthas, J.; Shah, A.; Silverberg, A.; Salamon, N.; Schneider, B. N.; Joshi, S. H.; O'Connor, M. J.; O'Neill, J.

2026-05-26 psychiatry and clinical psychology
10.64898/2026.05.25.26354065 medRxiv
Show abstract

Background: Prior neuroimaging suggests brain differences between children with attention deficit hyperactivity disorder due to prenatal alcohol exposure (ADHD+PAE) and non-exposed children with ADHD due to other, e.g., familial, causes (ADHD-PAE). There has been interest in regional brain levels of ;gamma-aminobutyric acid (GABA) and glutamate (Glu) measured in vivo with magnetic resonance spectroscopy (MRS) as possible indicators of local inhibitory, respectively, excitatory activity in ADHD. For the first time, we report here a comparison of GABA and Glu in ADHD+PAE vs. ADHD-PAE. Methods: At 3 T, we used J-difference-edited single-voxel MRS to assay GABA and Glu in 28 children with ADHD+PAE, 20 with ADHD-PAE, and 28 typically developing (TD) controls, all aged 8-14 years. MRS was sampled from midline anterior middle cingulate cortex (aMCC), the cognitive cingulate considered functionally relevant to ADHD. Spectra were fit with custom software, including a unique technique for isolating the GABA signal from the confounding macromolecular baseline (MMBL). Results: aMCC GABA was higher in ADHD+PAE and ADHD-PAE than in TD. GABA increased with age in TD, but not in ADHD+PAE or ADHD-PAE. Similar effects were observed for the ratios GABA/Glu and GABA/Glx. For GABA+MMBL (GABA+) these effects were not seen, rather GABA+ and MMBL increased with age for the ADHD+PAE group only. No significant effects were found for Glu or Glx. Conclusions: GABA in the aMCC does not distinguish the two etiologies of ADHD, rather elevated GABA that follows an abnormal developmental appears to be common to both. High GABA may reflect increased inhibition of the aMCC impairing its cognitive functions. GABA+ results in ADHD may not tract reliably with underlying GABA values. Negative results for Glu and Glx should be reexamined at shorter echo-times.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
NeuroImage: Clinical
132 papers in training set
Top 0.1%
18.8%
2
Translational Psychiatry
219 papers in training set
Top 0.5%
10.2%
3
Alcoholism: Clinical and Experimental Research
13 papers in training set
Top 0.1%
4.9%
4
PLOS ONE
4510 papers in training set
Top 30%
4.9%
5
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
62 papers in training set
Top 0.4%
3.7%
6
Alcohol, Clinical and Experimental Research
12 papers in training set
Top 0.1%
2.9%
7
Journal of Neurodevelopmental Disorders
15 papers in training set
Top 0.1%
2.4%
8
Scientific Reports
3102 papers in training set
Top 49%
2.1%
9
Psychiatry Research: Neuroimaging
16 papers in training set
Top 0.1%
2.1%
50% of probability mass above
10
Developmental Cognitive Neuroscience
81 papers in training set
Top 0.3%
1.9%
11
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
22 papers in training set
Top 0.1%
1.9%
12
Biological Psychiatry Global Open Science
54 papers in training set
Top 0.6%
1.8%
13
Autism Research
32 papers in training set
Top 0.3%
1.7%
14
Human Brain Mapping
295 papers in training set
Top 3%
1.7%
15
Frontiers in Psychiatry
83 papers in training set
Top 2%
1.7%
16
Acta Neuropsychiatrica
12 papers in training set
Top 0.5%
1.5%
17
Neuroscience & Biobehavioral Reviews
43 papers in training set
Top 0.4%
1.5%
18
Psychiatry and Clinical Neurosciences
11 papers in training set
Top 0.1%
1.5%
19
Brain and Behavior
37 papers in training set
Top 0.7%
1.3%
20
Journal of Psychiatric Research
28 papers in training set
Top 0.5%
1.3%
21
JAMA Network Open
127 papers in training set
Top 3%
1.1%
22
Addiction Biology
47 papers in training set
Top 0.6%
1.0%
23
Molecular Psychiatry
242 papers in training set
Top 3%
1.0%
24
European Neuropsychopharmacology
15 papers in training set
Top 0.5%
0.9%
25
Neuropsychopharmacology
134 papers in training set
Top 2%
0.9%
26
Journal of Psychopharmacology
14 papers in training set
Top 0.4%
0.9%
27
Progress in Neuro-Psychopharmacology and Biological Psychiatry
36 papers in training set
Top 0.9%
0.8%
28
Pharmacology Biochemistry and Behavior
17 papers in training set
Top 0.3%
0.8%
29
BMC Psychiatry
22 papers in training set
Top 0.7%
0.8%
30
Biological Psychiatry
119 papers in training set
Top 3%
0.7%